Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Temple

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|March 20, 2003
Defining dose decreaseRobert J Temple
Journal of the National Cancer Institute|January 2, 2003
Implications of effects in placebo groupsRobert J Temple
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2003
Study designs in osteoporosisRobert J Temple
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Enrichment designs: efficiency in development of cancer treatmentsRobert J Temple
American Journal of Therapeutics|May 21, 2003
Vitamin C hypertensionRobert J Temple
American Heart Journal|October 18, 2003
Choice of treatment: outcomes and treatment goalsRobert J Temple
Archives of Internal Medicine|February 13, 2003
Continued need for placebo in many cases, even when there is effective therapyRobert J Temple, Robert Meyer
JACC. Cardiovascular Interventions|April 8, 2017
The Devil Is Always in the DetailsKaren A Hicks, Robert J Temple
JAMA|May 1, 2002
Safety of newly approved drugs: implications for prescribingRobert J Temple, Martin H Himmel
The New England Journal of Medicine|September 8, 2004
Homocysteine as a predictive factor for hip fracture in older personsSusan S Ellenberg, David G Orloff, Robert J Temple
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|March 20, 2003
Defining dose decreaseRobert J Temple
Journal of the National Cancer Institute|January 2, 2003
Implications of effects in placebo groupsRobert J Temple
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2003
Study designs in osteoporosisRobert J Temple
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Enrichment designs: efficiency in development of cancer treatmentsRobert J Temple
American Journal of Therapeutics|May 21, 2003
Vitamin C hypertensionRobert J Temple
American Heart Journal|October 18, 2003
Choice of treatment: outcomes and treatment goalsRobert J Temple
Archives of Internal Medicine|February 13, 2003
Continued need for placebo in many cases, even when there is effective therapyRobert J Temple, Robert Meyer
JACC. Cardiovascular Interventions|April 8, 2017
The Devil Is Always in the DetailsKaren A Hicks, Robert J Temple
JAMA|May 1, 2002
Safety of newly approved drugs: implications for prescribingRobert J Temple, Martin H Himmel
The New England Journal of Medicine|September 8, 2004
Homocysteine as a predictive factor for hip fracture in older personsSusan S Ellenberg, David G Orloff, Robert J Temple
Pageof 3